L2M – Small Molecule Targeting TDP-43 aggregation as new therapeutics for ALS

In this project, the team will build a strong business foundation for a startup vehicle ‘Neuropeutics Inc’ to conduct further R&D and commercialize a new effective treatment for neurodegenerative diseases, namely ALS and FTD. That is, the team will develop a sustainable business model, a financial budget, a funds raising plan and marketing material. The […]

Read More
L2M – Validating Perioperative Solutions with PrehabRx

Surgery places significant stress on the body, much like running a marathon does. However, while marathon runners rigorously train before their race, most Canadians are not preparing for surgeries. Not only does a wealth of data exist supporting the notion of “better in, better out”, when it comes to surgery outcomes, but being in a […]

Read More
L2M – NorthMiRs Market Research

NorthMiRs is developing nanotechnology-enabled gene therapies for the treatment of sepsis. We have determined microRNAs that are dysregulated in septic patients and packaged them into a stable, synthetic, and scalable lipid nanoparticle delivery vehicle. Our lead therapeutic, NM-001, a miRNA replacement therapy for sepsis-associated cardiomyopathy has been shown to be anti-inflammatory, anti-microbial and protects organs […]

Read More
L2M – EPAID Technology: EPilepsy AI-Driven Technology

EPAID Technology: EPilepsy AI-Driven Technology aims to automate electrophysiological signal processing practice to assist clinicians in the treatment of epilepsy. We will partner with Springboard, who provides strategically positioned resources to Atlantic Canadian universities and colleges alike, helping them transfer both knowledge and technology into the private sector.

Read More
L2M – Clinical Development of a Novel NanoString Assay Predicts Survival and Clinical Outcomes in Myelofibrosis Patients

Myelofibrosis is a chronic and life-threatening blood disease. There is a need for accurate risk stratification approaches to guide personalized medicine decisions for these patients. To address this need, we developed a non-invasive blood-based test that is cost-effective, scalable and accurate. Through the Lab2Market program we will explore the market and develop the business case […]

Read More
Embedded systems design for a novel environmental monitoring system

Spero Analytics is an IoT startup which deploys wireless environmental monitoring systems for the waste management and oil and gas industries. The core of our technology is a proprietary mesh network which can transmit data from sensors without the need for cellular infrastructure, using little energy, and requiring minimal maintenance. This project will focus on […]

Read More
L2M- Remote Care: Empowering patients through Remote Self-administered Medical assessment.

“RemoteCare” is a novel initiative that empowers individuals to conduct part of their medical assessments independently via a user-friendly remote digital solution. By enabling self-assessments, it reduces physician workload, minimizes wait times, and ensures quicker access to medical assistance, especially in underserved areas. However, its progress hinges on gaining the trust of traditional healthcare providers, […]

Read More
L2M-A Novel Titanium-Enriched Bioactive Glass to Enhance Enamel Mineralization, Whiteness, and Hardness.

This project is aimed at supporting the translation of research innovation from the laboratory into the market. Our proposed innovation involves the use of a newly improved biomaterial in toothpastes to help transform oral health and hygiene. The proposed toothpaste will be effective in addressing tooth caries and discoloration, and simultaneously increase enamel hardness to […]

Read More
L2M- Unobtrusive Monitoring of Heart Failure via Ballistocardiograph

In Canada, heart failure (HF) has a 30-day re-admission rate of 17.6%. While patient care at home via follow-ups and self-management may reduce this rate, factors including physical fatigue and cognitive frailty delay follow-up visits and impair the patient’s ability to self-manage. An implantable solution such as CardioMEMS is available to monitor HF, however, its […]

Read More
Creating an anticipatory data ethics protocol for emerging nature-based solutions

Ethical data governance practices continue to shift with the emergence of digital technologies like blockchain and artificial intelligence. As these technologies begin to integrate more with climate and nature-based solutions, unique implications appear around data collection, handling, and use. Established concerns about privacy, consent, and data transparency present themselves, along with new considerations where information […]

Read More